ConnectM Technology Solutions, Inc. (CNTM): Nasdaq/NYSE listing notice — ConnectM receives Nasdaq deficiency notice for MVPHS below $15M threshold

ConnectM Technology Solutions, Inc.

Received Nasdaq notice on Dec 13, 2024 that MVPHS was below $15M for 33 consecutive business days.
Compliance period of 180 days, until June 11, 2025, to regain compliance.
Can regain compliance if MVPHS closes at $15M or more for 10 consecutive business days.
Failure to regain compliance may lead to delisting; company can appeal.
No immediate effect on listing or trading of common stock on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

ConnectM Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(C)

Exact text from the filing

December 13, 2024, ConnectM Technology Solutions, Inc., a Delaware corporation (the " Company "), received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (" Nasdaq ") indicating that based upon Nasdaq’s review of the Company’s Market Value of Publicly Held Shares (MVPHS) for the 33 consecutive business days prior to the date of the letter, the Company no longer meets the requirements of Nasdaq Listing Rule 5450(b)(2)(C), which requires listed securities to maintain a minimum MVPHS of $15,000,000. However, Nasdaq rules also provide the Company a

View on SEC.gov

1 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ConnectM Technology Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-130252

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.